G Square
24 Savile Row, London, England, W1S 2ES, United Kingdom
Overview
G Square is a leading healthcare private equity investor in Europe, focusing on mid-market projects with a high potential for growth. G Square provides between €30 and €60m of equity in each healthcare investment deal, and can also bring additional co-investment from its limited partners (LPs). G Square capitalises on its expertise in healthcare private equity and capital investments, as well as a deep industry knowledge across its dealings in Europe, which allows the G Square team, working alongside the entrepreneurs, to contribute actively to the strategic and operational development of its portfolio companies. The team at G Square have a strong foundation in entrepreneurship. With this, and a keen understanding of medical investments of all types, G Square has the experience needed to radically improve the business and organisational models of the projects it invests in. Currently operating in ten countries across Europe, G Square invests in a range of healthcare projects, including: mental health; social care; surgical, medical and dental services; diagnostic and therapeutic devices; equipment providers; and more, with the exception of biotech companies and projects. G Square acts as a lead investor in projects while developing a close working relationship with its portfolio companies’ management, as well as serving on companies’ boards of directors. As a signatory to the Principles of Responsible Investment supported by the United Nations, G Square commits to incorporate Environment Social Governance issues in its decision-making and ownership practices.
- Total investments
- 2
- Lead investments
- 2
- Investments · 12mo
- 0
- Active investors
- 5
Sector focus
- Finance
- Financial Services
- Venture Capital
Investment portfolio
- Pharmacy2U
Led · Equity · Apr 2018
Pharmacy2U is a UK NHS online pharmacy that operates a repeat prescription and medication-delivery service, led by CEO Mark Livingstone. Patients register and order medication through Pharmacy2U, which arranges prescriptions with their GP, handles dispensing and delivery, and sends reorder reminders. The service is capable of dispensing one million prescription items each month. Pharmacy2U also offers a private online doctor service with registered GPs and operates sister company ChemistDirect.co.uk for over-the-counter medicines and healthcare products. The company secured a further £40m in funding and intends to use the proceeds to grow its online service. Pharmacy2u is a Leeds, UK-based NHS-approved online-only pharmacy that offers a home delivery repeat prescription service for NHS patients. It provides clinical advice and medication-management assistance from qualified pharmacists. Its dispensing hub is capable of handling up to 700,000 prescription items a month. Ten months earlier the business received a £10m growth capital investment from BGF to support its merger with ChemistDirect.co.uk, creating a business with the UK’s largest customer base. The company intends to use the newly raised funds to accelerate its marketing strategy and deliver long-term growth. Pharmacy2u is led by CEO Mark Livingstone, CFO Gary Dannatt and COO Daniel Lee.
- zahnarztzentrum.ch
Led · Equity · Sep 2010
zahnarztzentrum.ch is a provider of dental services operating 10 branded service centres in German-speaking Switzerland. The company employs around 220 staff and expected sales of approximately €28m in 2010. Its core offering is in-clinic dental services delivered through its network of centres. Founders and main shareholders Dr. Sara Hürlimann and Christoph Hürlimann will remain in charge of management and development. Together with its new investor, the company plans to expand further within Switzerland and to deploy its model in other European countries. The partnership with G Square is presented as bringing healthcare-sector expertise and pan‑European regulatory experience to support that expansion.